Does the literature support medications for stable, monomorphic ventricular tachycardia?
EMDocs
DECEMBER 23, 2024
Major adverse cardiac events 40 minutes after giving the antiarrhythmic. The following table shows their results, take a look: Note that procainamide leads with less adverse cardiac events. Procainamide therapy was associated with less major cardiac adverse events and a higher proportion of tachycardia termination within 40 min.
Let's personalize your content